×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
IBRX – immunitybio, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
IBRX
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/31
08:11 am
ibrx
ImmunityBio, Inc. (NASDAQ: IBRX) had its "buy" rating re-affirmed by analysts at D. Boral Capital. They now have a $30.00 price target on the stock.
Low
Report
ImmunityBio, Inc. (NASDAQ: IBRX) had its "buy" rating re-affirmed by analysts at D. Boral Capital. They now have a $30.00 price target on the stock.
3/27
06:19 pm
ibrx
"This Is Existential": Billionaire Cancer Researcher Says Covid & Vaccine Likely Causing Surge In Aggressive Cancers [zero hedge]
Medium
Report
"This Is Existential": Billionaire Cancer Researcher Says Covid & Vaccine Likely Causing Surge In Aggressive Cancers [zero hedge]
3/26
06:12 am
ibrx
ImmunityBio to Host Investor Day [Yahoo! Finance]
Low
Report
ImmunityBio to Host Investor Day [Yahoo! Finance]
3/26
06:00 am
ibrx
ImmunityBio to Host Investor Day
Low
Report
ImmunityBio to Host Investor Day
3/25
08:13 pm
ibrx
Is ImmunityBio, Inc. (NASDAQ:IBRX) The Top Penny Stock That Will Skyrocket? [Yahoo! Finance]
Low
Report
Is ImmunityBio, Inc. (NASDAQ:IBRX) The Top Penny Stock That Will Skyrocket? [Yahoo! Finance]
3/13
01:58 pm
ibrx
ImmunityBio, Inc. (NASDAQ: IBRX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $8.00 price target on the stock.
Low
Report
ImmunityBio, Inc. (NASDAQ: IBRX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $8.00 price target on the stock.
3/13
10:10 am
ibrx
ImmunityBio, Inc. (NASDAQ: IBRX) had its "buy" rating re-affirmed by analysts at D. Boral Capital. They now have a $30.00 price target on the stock.
Low
Report
ImmunityBio, Inc. (NASDAQ: IBRX) had its "buy" rating re-affirmed by analysts at D. Boral Capital. They now have a $30.00 price target on the stock.
3/13
09:00 am
ibrx
ImmunityBio Announces First Dosing of Recombinant BCG (rBCG) in the U.S. and 60 Sites Are in the Process of Launching
Low
Report
ImmunityBio Announces First Dosing of Recombinant BCG (rBCG) in the U.S. and 60 Sites Are in the Process of Launching
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
3/19
08:14 am
ibrx
Form 8-K ImmunityBio, Inc. For: Mar 13
Low
Report
Form 8-K ImmunityBio, Inc. For: Mar 13
3/3
07:48 am
ibrx
Form 10-K ImmunityBio, Inc. For: Dec 31
High
Report
Form 10-K ImmunityBio, Inc. For: Dec 31
3/3
07:42 am
ibrx
Form 8-K ImmunityBio, Inc. For: Mar 03
High
Report
Form 8-K ImmunityBio, Inc. For: Mar 03
2/25
09:12 pm
ibrx
Form 4 ImmunityBio, Inc. For: Feb 22 Filed by: LAUER REGAN J
Low
Report
Form 4 ImmunityBio, Inc. For: Feb 22 Filed by: LAUER REGAN J
2/25
09:11 pm
ibrx
Form 4 ImmunityBio, Inc. For: Feb 22 Filed by: Adcock Richard
Low
Report
Form 4 ImmunityBio, Inc. For: Feb 22 Filed by: Adcock Richard
2/25
09:11 pm
ibrx
Form 4 ImmunityBio, Inc. For: Feb 22 Filed by: Sachs David C.
Low
Report
Form 4 ImmunityBio, Inc. For: Feb 22 Filed by: Sachs David C.
2/25
09:11 pm
ibrx
Form 4 ImmunityBio, Inc. For: Feb 22 Filed by: Simon Barry J.
Low
Report
Form 4 ImmunityBio, Inc. For: Feb 22 Filed by: Simon Barry J.
2/25
09:11 pm
ibrx
Form 4 ImmunityBio, Inc. For: Feb 22 Filed by: SOON-SHIONG PATRICK
Low
Report
Form 4 ImmunityBio, Inc. For: Feb 22 Filed by: SOON-SHIONG PATRICK
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: